Melanoma Clinical Trial

A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions

Summary

The incidence of malignant melanoma has increased dramatically in recent decades. In 1930, the lifetime risk of an individual in the United States developing melanoma was 1 in 1,500. This has been exponentially increasing over the years with the risk estimated to be 1 in 75 in 2000 . According to the American Cancer Society, approximately 59,580 new cases of melanoma will be diagnosed in the United States in 2005 and about 7,770 people are expected to die of the disease.

View Full Description

Full Description

The researcher ucan use special imaging devices to obtain information about a typical mole and melanoma and use this information to determine the different between malignant and benign melanized lesions. The imaging devices are, Modified Two Layer Diffuse Optical Spectroscopy,multi-spectral imaging, and Spatially Modulated Quantitative Spectroscopy can use to measure atypical moles and melanoma and correlate the results of the biopsy tissue histology.

The imaging devices can quantify melanin, oxy and deoxy hemoglobin concentration, water, lipid and reduced scattering coefficients and can compare results to histopathologic. Atypical moles and melanoma have a different optical profile based on physiological parameters compared to benign nevus.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years or older.
Have atypical mole/s and melanoma

Exclusion Criteria:

Age less than 18 years old.
have NO atypical mole/s and melanoma

Study is for people with:

Melanoma

Estimated Enrollment:

37

Study ID:

NCT00633516

Recruitment Status:

Completed

Sponsor:

University of California, Irvine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Beckman Laser Medical clinic, UCI
Irvine California, 92612, United States
UCIMC
Orange California, 92868, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

37

Study ID:

NCT00633516

Recruitment Status:

Completed

Sponsor:


University of California, Irvine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider